Hologic have just announced that the U.S. Food and Drug Administration (FDA) has approved the company’s 3DQuorum Imaging Technology, powered by Genius AI.
The 3DQuorum technology works in tandem with Hologic’s Clarity HD high resolution imaging technology to reduce tomosynthesis image volume for radiologists by 66 percent.
In 2009, Hologic revolutionized breast cancer screening with the introduction of the Genius 3D mammography exam, the only mammogram clinically proven and FDA-approved as superior to 2D mammography alone, for all women, including those with dense breasts.
Today, there are nearly 7,000 Hologic 3D mammography systems in use in the U.S. alone, and tomosynthesis is now the standard of care for annual breast cancer screening. These advancements serve as the foundation for Genius AI technology, Hologic’s new core artificial intelligence platform designed to provide advanced cancer detection, operational efficiency, and clinical decision support across the breast cancer care continuum.
3DQuorum technology uses Genius AI-powered analytics to uniquely reconstruct high-resolution 3D data to produce 6 mm “SmartSlices.” These analytics identify clinically relevant regions of interest and preserve important features during reconstruction of the SmartSlices. SmartSlices expedite read time by reducing the number of images for radiologists to review, without compromising image quality, sensitivity or accuracy. With 3DQuorum technology, the number of 3D images to review is reduced by two-thirds, saving an average of one hour per eight hours of daily image interpretation time.
“Superior breast cancer detection begins with our superior imaging, and only Hologic offers a comprehensive breast health ecosystem that improves outcomes, reduces costs and increases patient and clinician satisfaction,” said Pete Valenti, Hologic’s Division President, Breast and Skeletal Health Solutions. “3DQuorum technology is the first of many products to come powered by our new Genius AI technology platform, which will further revolutionize cancer detection in the coming years. 3DQuorum technology delivers meaningful productivity gains for radiologists, due to a significant reduction in read time.”
Benefits of 3DQuorum
Accurate and Timely Diagnosis: The Genius AI powered software identifies clinically relevant regions of interest and preserves important features during the creation of SmartSlices. Each high-resolution SmartSlice overlaps the previous one by 3mm, ensuring there is no loss of 3D image data and continuity in scrolling.
Expedited Clarity HD High Resolution 3D Exam Read Times: When a radiologist reads SmartSlices instead of 1mm slices, the number of 3D images to review is reduced by 2/3. On average there is an interpretation time saving of 1 hour per day, based on 8 hours of image interpretation time per day.
High-Resolution File Size Reduction: The 3DQuorum technology reduces the typical Hologic Clarity HD and Intelligent 2D study size by over 50%, bringing the storage space and network impact back down to that of standard resolution 3D imaging.
The world leader in mammography, Hologic has expanded its product portfolio significantly, through insight-driven innovation and strategic acquisitions to address the entire clinical continuum of breast cancer diagnosis and care. From digital specimen radiography and stereotactic breast biopsy systems, to breast biopsy markers and surgical guidance systems – Hologic’s comprehensive suite of products is designed to meet the unmet and changing needs of patients and clinicians.
3DQuorum technology is available as part of the new Hologic Clarity HD Plus technology package for use with existing and future Hologic 3D mammography systems. The Genius 3D Mammography exam (also known as the Genius exam) is only available on a Hologic 3D Mammography system. It consists of a 2D and 3D image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D image set.
Marlborough, MA USA